Home -> Law Blog Directory -> Intellectual Property Law Blogs -> TinytechIP
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: TinytechIPUS Patent 7634162 - CNT de-magnification lens for nanolithography
This patent from Boston College suggests manufacturing methods to produce nano-optics which extend the resolution of optical lithography. Claim 1 reads:
1. A de-magnifying lens for use in a standard photolithography system comprising: a film having a top surface, a bottom surface and a plurality of cylindrical channels containing a dielectric material; and an array of carbon nanotubes penetrating and converging through the film through the plurality of cylindrical channels, wherein an image on the top surface of the film is converted into a de-magnified image on the bottom surface of the film by the carbon nanotubes, wherein each carbon nanotube connects a light-receiving pixel on the top surface of the film with a light-emitting pixel on the bottom surface of the film, and wherein the light-receiving pixels on the top surface of the film are indirectly mapped to the light-emitting pixels on the bottom surface of the film by scrambled wiring through a nano-coaxial transmission line.
Full post as published by TinytechIP on December 21, 2009 (boomark / email).
Bausch Lomb Renu Moistureloc Linked to Eye Infection Fusarium Keratiti
Contact Lens Solution Product Recall
Bausch Lomb Renu Moistureloc Recall
Contact Lens Solution Product Recall
ReNu Lens Cleaner
600 Lawuits Settled and Counting
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment

New Labeling Considered for ReNu with MoistureLoc
Contact Lens Solution Lawsuits Continue
ReNu Lens Solution: Two Years After Recall, Lawsuits Keep Coming
"Substantially Embodied" Method Claims Exhausted by Licensed Sale of Patent
FDA Looks to Stricter Rules for AMO Solution







